Layal Bou Harfouch
Drug Policy Analyst
Layal Bou Harfouch is a Drug Policy Analyst at Reason Foundation, where her work focuses on harm reduction. Bou Harfouch’s experience spans multiple facets of addiction treatment and drug policy, informed by her extensive background in translational health research and clinical coordination.
Bou Harfouch previously coordinated multisite clinical trials in addiction at Johns Hopkins University School of Medicine, Division of Addiction Medicine, where she served as a Senior Clinical Research Coordinator testing a monthly injectable formulation of buprenorphine. She most recently held a position as a research coordinator at the Adolescent Addiction Recovery Center at Detroit Medical Center, where she analyzed clinic outcomes and success rates.
Bou Harfouch holds an M.S. in Biotechnology from Johns Hopkins University and a B.S. in Kinesiology with a minor in Substance Use Disorder Prevention, Intervention, and Treatment from Central Michigan University.
Outside of her professional life, Bou Harfouch is dedicated to self-care and wellness practices, including yoga, and she cherishes spending quality time with her family. These pursuits provide her with balance and fulfillment, supporting her in both her personal and professional endeavors.
-
Unreliable drug tests shouldn’t be used to separate mothers from their newborns
Informed consent and confirmatory testing should be standards for any drug testing that could affect a mother’s parental rights.
-
Why smoking cessation programs should embrace vaping
Contrary to widespread belief, there is substantial proof that e-cigarettes are a viable and successful cessation tool.